 Prevention cardiovascular disease risks benefits aspirin Aspirin benefit cardiovascular disease randomized trials categories patients secondary prevention history myocardial infarction MI transient cerebral ischemia unstable angina pectoris trials significant reductions aspirin occurrence important vascular event nonfatal MI nonfatal stroke vascular death nonfatal MI nonfatal stroke vascular mortality MI Second International Study Infarct Survival significant reduction five-week vascular mortality one-month regimen daily aspirin hours onset symptoms suspected MI Aspirin reinfarction nonfatal stroke important vascular events primary prevention US Health Study PHS significant reduction occurrence first MI healthy male physicians numbers strokes vascular deaths insufficient conclusions endpoints aspirin clear benefit MI stroke vascular death secondary prevention MI beneficial primary prevention MI men data effects stroke vascular death inconclusive